Bristol To Name New R&D Head Shortly
This article was originally published in The Pink Sheet Daily
Executive Summary
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
You may also be interested in...
Aranesp Performance Strong Heading Into "Transition" Time, Amgen Says
The company is talking with oncologists about Aranesp ahead of a switch in Medicare reimbursement in January 2005. U.S. sales for the red blood cell product were up 32% in the third quarter.
Chiron Fluvirin Remediation Plan Design Underway
The four-pronged plan will address “bio-burden,” manufacturing techniques, quality systems and execution, CEO Pien says. Chiron has met twice with U.K. authorities and hopes to realize similar progress with FDA soon.
Excise Tax On Flu Vaccine Added By Congress
Flu vaccine appears close to inclusion in the Vaccine Injury Compensation Program after Congress' approval of an excise tax on the vaccine